SFX by Ex Libris Inc.

Title:	Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night
Source:	Nucleic Acids Research [0305-1048] de-Haro, D yr:2014

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Belancio, Victoria P. "The aging clock and circadian control of metabolism and genome stability." Frontiers in genetics 5 (2015): 455-455.
description	2.	Heusch, G. "Response to Letter by Zaugg et al: STAT5 Activation and Cardioprotection By Remote Ischemic Preconditioning in Patients Undergoing Coronary Revascularization During Isoflurane Anesthesia." Circulation research 110.5 (2012).
description	3.	Bubenik, G. "MELATONIN AND AGING: PROSPECTS FOR HUMAN TREATMENT." Journal of physiology and pharmacology 62.1 (2011): 13-19.
description	4.	Labat Robert, J. "Longevity and aging. Mechanisms and perspectives." Pathologie et biologie 63.6 (2015): 272-6.
description	5.	Belancio, Victoria P. "LINE-1 activity as molecular basis for genomic instability associated with light exposure at night." Mobile Genetic Elements 5.3 (2015): 1-5.
description	6.	Jazwinski, S M M. "Mitochondria to Nucleus Signaling and the Role of Ceramide in Its Integration into the Suite of Cell Quality Control Processes during Aging." Ageing research reviews 23 (2014): 67-74.
description	7.	Díaz Muñoz, M. "The circadian timing system: a recent addition in the physiological mechanisms underlying pathological and aging processes." Aging and disease 5.6 (2014): 406-18.
description	8.	Tunkel, David E. "Clinical practice guideline: tinnitus." Otolaryngology - head and neck surgery 151.2 Suppl (2014): 1-.
description	9.	Zaugg, M. "Remote ischemic preconditioning is redundant in patients undergoing coronary artery bypass graft surgery who are already protected by volatile anesthetics." Circulation research 110.5 (2012).
description	10.	Karuppasamy, P. "Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation?" Basic Research in Cardiology 106.4 (2011): 511-519.
description	11.	Hollway, Jill A. "Pharmacological treatment of sleep disturbance in developmental disabilities: A review of the literature." Research in developmental disabilities 32.3 (2011): 939-962.
description	12.	Forman, K. "Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging." Journal of pineal research 49.3 (2010): 312-320.
description	13.	Zawilska, Jolanta B. "Physiology and pharmacology of melatonin in relation to biological rhythms." Pharmacological reports 61.3 (2009): 383-410.
description	14.	Sharma, M.. "Circadian rhythms of melatonin and cortisol in aging." Biological psychiatry 25.3 (1989): 305-319.
description	15.	ROBERTS, JOAN E. "Light and Immunomodulation." Annals of the New York Academy of Sciences 917.1 (2000): 435-445.
description	16.	Singh, M. "Melatonin: functions and ligands." Drug discovery today 19.9 (2014): 1410-1418.
description	17.	Kim, J.-S. H. "Tinnitus in children: Association with stress and trait anxiety." The Laryngoscope 122.10 (2012): 2279-2284.
description	18.	Ambriz-Tututi, M. "Melatonin: A hormone that modulates pain." Life Sciences 84.15-16 (2009): 489-498.
description	19.	Van Geijlswijk, Wiebe M. "Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis." Developmental Medicine and Child Neurology 51.5 (2009): 340-9.
description	20.	Blask, Blask E. "Melatonin, sleep disturbance and cancer risk." Sleep medicine reviews 13.4 (2008): 257-264.